Prestige Consumer Healthcare Proxy Statement Filed

Ticker: PBH · Form: DEF 14A · Filed: Jul 5, 2024 · CIK: 1295947

Prestige Consumer Healthcare Inc. DEF 14A Filing Summary
FieldDetail
CompanyPrestige Consumer Healthcare Inc. (PBH)
Form TypeDEF 14A
Filed DateJul 5, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$1,125 Million, $4.21, $240 million
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, annual-meeting

Related Tickers: PBH

TL;DR

Proxy statement out for Prestige Consumer Healthcare (PBH) - vote on directors & auditors Aug 6.

AI Summary

Prestige Consumer Healthcare Inc. filed its definitive proxy statement on July 5, 2024, for its annual meeting on August 6, 2024. The filing details executive compensation, board nominations, and other corporate governance matters for the fiscal year ending March 31, 2024. Key proposals include the election of directors and the ratification of PricewaterhouseCoopers LLP as its independent registered public accounting firm.

Why It Matters

This filing provides shareholders with crucial information to make informed voting decisions on company leadership and governance, impacting the company's strategic direction and financial oversight.

Risk Assessment

Risk Level: low — This is a routine annual proxy filing, not indicating any immediate financial distress or unusual corporate events.

Key Numbers

  • 20240806 — Annual Meeting Date (Shareholders will vote on proposals at this meeting.)
  • 0331 — Fiscal Year End (The financial reporting period covered by the proxy statement.)

Key Players & Entities

  • Prestige Consumer Healthcare Inc. (company) — Registrant
  • August 6, 2024 (date) — Annual Meeting Date
  • March 31, 2024 (date) — Fiscal Year End
  • PricewaterhouseCoopers LLP (company) — Independent Registered Public Accounting Firm

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose is to provide shareholders with information required for the annual meeting, including details on director nominations, executive compensation, and voting on corporate matters.

When is the annual meeting of Prestige Consumer Healthcare Inc. scheduled?

The annual meeting is scheduled for August 6, 2024.

Who is nominated to serve as independent registered public accounting firm for the upcoming fiscal year?

PricewaterhouseCoopers LLP is nominated to serve as the independent registered public accounting firm.

What is the fiscal year end for Prestige Consumer Healthcare Inc. as stated in the filing?

The fiscal year end is March 31.

What is the company's former name?

The company was formerly known as Prestige Brands Holdings, Inc. and Prestige Household Brands, Inc.

Filing Stats: 4,410 words · 18 min read · ~15 pages · Grade level 13.8 · Accepted 2024-07-05 12:00:39

Key Financial Figures

  • $1,125 Million — ensation. Top Line Trends Revenue of $1,125 Million Consumption was very strong for the y
  • $4.21 — onal OTC segment EPS Adjusted EPS of $4.21 Strong financial profile leading to s
  • $240 million — ation Adjusted Free Cash Flow of about $240 million Reduced debt to lowest level in recen

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 34 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 36 COMPENSATION AND TALENT MANAGEMENT COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION 67 CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS 68 REPORT OF THE AUDIT AND FINANCE COMMITTEE 69 SUBMISSION OF STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS 71 FORM 10-K 72 GENERAL INFORMATION 73 VOTING MATTERS 75

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS 78 IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDERS MEETING TO BE HELD ON AUGUST 6, 2024: This Proxy Statement, the Proxy Card and the 2024 Annual Report to Stockholders are available at the "investors" tab of www.prestigeconsumerhealthcare.com, our internet website. You can submit a request for a copy of the Proxy Statement, Annual Report and Form of Proxy for any future stockholder meetings (including the meeting of stockholders to be held on August 6, 2024) to 1-800-831-7105, (Attention: Investor Relations), proxy@prestigebrands.com or the "contact us" tab at www.prestigeconsumerhealthcare.com. You can also contact us at the phone number, e-mail address and website set forth above to request directions to the location of the Annual Meeting of Stockholders so that you may attend the meeting and vote in person. TABLE OF CONTENTS PROXY SUMMARY PROXY SUMMARY ABOUT THE MEETING WHEN: WHERE: WHO: Tuesday, August 6, 2024 10:00 a.m. (Eastern Daylight Time) At the Company's offices 660 White Plains Road Tarrytown, New York 10591 Only stockholders of record at the close of business on June 10, 2024 will be entitled to vote at the Annual Meeting. VOTING MATTERS PROPOSAL BOARD'S RECOMMENDATION SEE PAGE 1 To elect the seven directors nominated by the Board of Directors and named in this Proxy Statement to serve until the 2025 Annual Meeting of Stockholders or until their earlier death, removal or resignation FOR each director nominee 19 Ronald M. Lombardi John E. Byom Celeste A. Clark James C. D'Arecca Sheila A. Hopkins John F. Kelly Dawn M. Zier 2 To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of Prestige Consumer Healthcare Inc. for the fiscal year ending March 31, 2025 FOR 29 3 To vote on a non-binding resolution to approve the compensation of our named executive officers as d

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.